Bhavik Kiran Bhulabhai, MD in Barrington, NH - Medicare Family Practice

Bhavik Kiran Bhulabhai, MD is a medicare enrolled "Family Medicine" physician in Barrington, New Hampshire. He graduated from medical school in 2014 and has 10 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Wentworth Douglass Physician Corporation and his current practice location is 8 Century Pines Dr Ste 2, Barrington, New Hampshire. You can reach out to his office (for appointments etc.) via phone at (603) 664-2135.

Bhavik Kiran Bhulabhai is licensed to practice in New Hampshire (license number 18648) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1689052623.

Contact Information

	Bhavik Kiran Bhulabhai, MD
	8 Century Pines Dr Ste 2, Barrington, NH 03825
	(603) 664-2135
	(603) 664-9128

Physician's Profile

Full Name	Bhavik Kiran Bhulabhai
Gender	Male
Speciality	Family Practice
Experience	10 Years
Location	8 Century Pines Dr Ste 2, Barrington, New Hampshire
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Bhavik Kiran Bhulabhai graduated from medical school in 2014

NPI Data:

NPI Number: 1689052623
Provider Enumeration Date: 05/11/2015
Last Update Date: 09/06/2018

Medicare PECOS Information:

PECOS PAC ID: 0244533941
Enrollment ID: I20180724001626

Medical Identifiers

Medical identifiers for Bhavik Kiran Bhulabhai such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1689052623	NPI	-	NPPES
3111907	Medicaid	NH

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	18648 (New Hampshire)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Cornerstone Vna	Rochester, NH	Home health agency
Wentworth-douglass Hospital	Dover, NH	Hospital
Frisbie Memorial Hospital	Rochester, NH	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Wentworth Douglass Physician Corporation	5496749848	372

News Archive

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

A grandfather-of-three from Tameside is helping University of Manchester researchers become the first in the world to assess all the genetic links with Chronic Pulmonary Aspergillosis (CPA) - a debilitating fungal lung infection that claims the lives of thousands of people in the UK and millions more worldwide.

Abcodia raises £5.25 million funding to launch ovarian cancer screening test, ROCA

Abcodia today announced that it has raised £5.25 million funding from existing and new investors to bring the world's most sensitive and specific ovarian cancer screening test, ROCA to market.

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

Tibotec Pharmaceuticals today announced its submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for TMC278 (rilpivirine, as hydrochloride), an investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for the treatment of HIV. The proposed indication would make TMC278 available for once-daily use with other antiretroviral agents in treatment-naive HIV-1-infected adults.

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs and companion diagnostics, today announced the treatment of its first patient in a multicentre, open, non-comparative Phase III study to investigate the efficacy, safety, and pharmacokinetics of two subcutaneous (SC) injections of Debio 8206 (triptorelin pamoate 22.5 mg 6-month formulation) in patients with advanced prostate cancer.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Bhavik Kiran Bhulabhai allows following entities to bill medicare on his behalf.

Entity Name	Wentworth Douglass Physician Corporation
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1447352430 PECOS PAC ID: 5496749848 Enrollment ID: O20040409000433

News Archive

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

Abcodia raises £5.25 million funding to launch ovarian cancer screening test, ROCA

Abcodia today announced that it has raised £5.25 million funding from existing and new investors to bring the world's most sensitive and specific ovarian cancer screening test, ROCA to market.

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bhavik Kiran Bhulabhai is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bhavik Kiran Bhulabhai, MD 789 Central Ave, Dover, NH 03820-2526 Ph: (603) 664-2135	Bhavik Kiran Bhulabhai, MD 8 Century Pines Dr Ste 2, Barrington, NH 03825 Ph: (603) 664-2135

News Archive

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

Abcodia raises £5.25 million funding to launch ovarian cancer screening test, ROCA

Abcodia today announced that it has raised £5.25 million funding from existing and new investors to bring the world's most sensitive and specific ovarian cancer screening test, ROCA to market.

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

Family Medicine Doctors in Barrington, NH

Dr. Tracy Hamill, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 425 Rte 125, Barrington, NH 03825 Phone: 603-664-9003 Fax: 603-664-7493
Joan D Smith, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Century Pines Dr, Suite 2, Barrington, NH 03825 Phone: 603-664-2135 Fax: 603-664-9128
Dr. Ray Earl Wilt Iii, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 426 Calef Highway, Barrington, NH 03825 Phone: 603-664-9003 Fax: 603-664-0133
David A Cooper, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 8 Century Pines Drive, Suite 2, Barrington, NH 03825 Phone: 603-664-2135 Fax: 603-664-9128

Bhavik Kiran Bhulabhai, MD - Medicare Family Practice in Barrington, NH

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

Abcodia raises £5.25 million funding to launch ovarian cancer screening test, ROCA

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

Medicare Reassignments

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

Abcodia raises £5.25 million funding to launch ovarian cancer screening test, ROCA

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Manchester researchers become first in world to assess all genetic links with fungal lung infection CPA

Abcodia raises £5.25 million funding to launch ovarian cancer screening test, ROCA

Tibotec submits MAA for investigational HIV drug TMC278 to European Medicines Agency

Debiopharm initiates Debio 8206 Phase III study on advanced prostate cancer

Family Medicine Doctors in Barrington, NH